Merck & Co., Inc.
MRK · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $251,883,360 | $284,230,730 | $280,925,400 | $193,899,200 |
| - Cash | $13,242,000 | $6,841,000 | $12,694,000 | $8,096,000 |
| + Debt | $38,270,000 | $36,268,000 | $31,985,000 | $34,631,000 |
| Enterprise Value | $276,911,360 | $313,657,730 | $300,216,400 | $220,434,200 |
| Revenue | $64,168,000 | $60,115,000 | $59,283,000 | $48,704,000 |
| % Growth | 6.7% | 1.4% | 21.7% | – |
| Gross Profit | $48,975,000 | $43,989,000 | $41,872,000 | $35,078,000 |
| % Margin | 76.3% | 73.2% | 70.6% | 72% |
| EBITDA | $25,706,000 | $6,907,000 | $21,315,000 | $17,899,000 |
| % Margin | 40.1% | 11.5% | 36% | 36.8% |
| Net Income | $17,117,000 | $365,000 | $14,519,000 | $13,049,000 |
| % Margin | 26.7% | 0.6% | 24.5% | 26.8% |
| EPS Diluted | 6.74 | 0.14 | 5.71 | 5.14 |
| % Growth | 4,714.3% | -97.5% | 11.1% | – |
| Operating Cash Flow | $21,468,000 | $13,006,000 | $19,095,000 | $14,109,000 |
| Capital Expenditures | -$3,372,000 | -$3,863,000 | -$4,388,000 | -$4,448,000 |
| Free Cash Flow | $18,096,000 | $9,143,000 | $14,707,000 | $9,661,000 |